Contemporary hormonal contraception and risk of endometrial cancer in women younger than age 50: A retrospective cohort study of Danish women

Keyphrases

• Retrospective Cohort Study 100%
• Hormonal Contraception 100%
• Age 50 100%
• Endometrial Cancer 100%
• Risk Reduction 25%
• Carcinoma 25%
• Endometrial Cancer Risk 25%
• Confidence Interval 16%
• Progestin-only pill 16%
• Combined Hormonal Contraception 16%
• Levonorgestrel-releasing Intrauterine System (LNG-IUS) 16%
• Combined Contraceptives 16%
• Denmark 8%
• Low Risk 8%
• Poisson Regression 8%
• Rate Ratio 8%
• National Registry 8%
• Combined Oral Contraceptives 8%
• Duration of Use 8%
• Progestin 8%
• Incidence Rate 8%
• Tumor Subtype 8%
• National Cohort 8%
• Women of Reproductive Age 8%
• Specific Populations 8%
• Tumor-specific 8%
• Contraceptive Use 8%
• Specific Analysis 8%
• Preventive Fraction 8%
• Product-specific 8%
• Protopathic Bias 8%
• Rare Sarcoma 8%

Medicine and Dentistry

• Hormonal Contraception 100%
• Retrospective Cohort Study 100%
• Endometrial Cancer 100%
• Contraceptive Agent 61%
• Gestagen 23%
• Carcinoma 23%
• Cancer Risk 23%
• Cohort Analysis 7%
• Levonorgestrel 7%
• Oral Contraceptive Agent 7%
• Neoplasm 7%
• Risk Reduction 7%
• Sarcoma 7%
• Specific Tumor 7%
• Contraceptive Behavior 7%

Pharmacology, Toxicology and Pharmaceutical Science

• Cohort Study 100%
• Endometrium Cancer 100%
• Contraceptive Agent 61%
• Progestin 23%
• Carcinoma 23%
• Neoplasm 15%
• Levonorgestrel 7%
• Oral Contraceptive Agent 7%
• Sarcoma 7%